Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 489.35 3.73
Tata Pow 93.75 3.19
Hindalco 163.20 1.75
Ntpc Ltd 149.95 1.90
Gail 529.15 3.83
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Parenteral Drugs (India) Limited
Parenteral Drugs (India) Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:524689NSE:PDPLBloomberg:PDI@INReuters:PADG.BO
Market Lot: 1Face Value: 10ISIN Demat: INE904D01019
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
31-MAR-14 Parenteral Drugs India, one of the leading and fastest growing healthcare company, India announced commencement of production at the newly established plant of Punjab Formulations, a subsidiary of the company, situated at Village Ahirana, Dist. Hoshiarpur, Punjab. 15-MAR-13 Parenteral Drugs India announced that Goa Formulations, wholly owned subsidiary of the company, has executed an agreement with Fresenius Kabi India to sell its on...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
  -
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2014 (12)31-Mar-2013 (12)31-Mar-2012(12)
Net sales 1865.051872.162225.61
Other Income0.000.000.00
Total Income1865.051872.162225.61
Cost of goods sold2036.032094.912140.05
OPBDIT-170.98-222.7585.56
PAT-587.01-851.95-478.16
Gross Block---
Equity capital298.16258.67258.67
EPS (Rs.)-19.69-32.94-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)NANA-
Debt / Equity (x)---
Operating margin (% of OI)-9.2-11.9 3.8
Net margin (% of OI)-31.5-45.5-21.5
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
340, Laxmi Plaza
Laxmi Industrial Estate
New Link Road
Andheri (West)
Mumbai
Maharashtra-400 053
PHONE
(022) 6694 3547 / 2630 4940 / 4941
FAX
(022) 2633 3763
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer